RE:e1 & Rb2211 - Mea Culpa & Agree!Jwal,
No need to apologize . I am too frustrated with the lack of news flow. But I know Dr Tolekis works almost 20 hours a day, he basically stole the Immunosuppresion technology which he did singlehandly . He is putting the pieces to together . The pouch, the cells and immunotherapy . After we have proven the pouch is safe and able to produce insulin , the immunotherapy angle is the holy grail imo . The need of no immunosuppresion is key to unlock value in the company . That in addition to the number of indications that could be possible are also very positive. The fact Viacycte is looking for new Ceo and Silgon is looking for seems like almost their entire staff bodes well for Sernova. Vertex / Semma have not shown they have a viable device that works .
Again these are my opinions only . But once we get recognition from pharma anything is possible .
Elgin